{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:00:22Z","timestamp":1781485222925,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["R24TW008829"],"award-info":[{"award-number":["R24TW008829"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.sapharm.2016.05.049","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T02:24:55Z","timestamp":1464747895000},"page":"589-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient acceptability of and readiness-to-pay for pharmacy-based health membership plans to improve hypertension outcomes in Lima, Peru"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7370-0919","authenticated-orcid":false,"given":"Elisabeth","family":"Vodicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Antiporta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukimi","family":"Yshii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Zunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2016.05.049_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gheart.2012.02.001","article-title":"Resource needs for addressing noncommunicable disease in low- and middle-income countries: current and future developments","author":"Stenberg","year":"2012","journal-title":"Glob Heart"},{"key":"10.1016\/j.sapharm.2016.05.049_bib2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ypmed.2005.06.001","article-title":"Poverty is a predictor of non-communicable disease among adults in Peruvian cities","volume":"41","author":"Goldstein","year":"2005","journal-title":"Prev Med (Baltim)"},{"key":"10.1016\/j.sapharm.2016.05.049_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/10810730.2011.601394","article-title":"The economic effect of noncommunicable diseases on households and nations: a review of existing evidence","volume":"16 suppl 2","author":"Engelgau","year":"2011","journal-title":"J Health Commun"},{"key":"10.1016\/j.sapharm.2016.05.049_bib4","first-page":"2224","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21\u00a0regions, 1990-2010: a systematic analysis for the\u00a0Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet\u00a0[Internet]"},{"key":"10.1016\/j.sapharm.2016.05.049_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet [Internet]"},{"key":"10.1016\/j.sapharm.2016.05.049_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1756-0500-1-2","article-title":"Hypertension among adults in a deprived urban area of Peru - undiagnosed and uncontrolled?","volume":"1","author":"Davies","year":"2008","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.sapharm.2016.05.049_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/HPC.0b013e318285ef60","article-title":"The \u201crule of halves\u201d does not apply in Peru: awareness, treatment, and control of hypertension and diabetes in rural, urban, and rural-to-urban migrants","volume":"12","author":"Lerner","year":"2013","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.sapharm.2016.05.049_bib8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/hrt.2010.218537","article-title":"Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru","volume":"97","author":"Miranda","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.sapharm.2016.05.049_bib9","doi-asserted-by":"crossref","first-page":"e000610","DOI":"10.1136\/bmjopen-2011-000610","article-title":"Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol","volume":"2","author":"Miranda","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2016.05.049_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA [Internet]"},{"key":"10.1016\/j.sapharm.2016.05.049_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and\u00a0low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA [Internet]"},{"issue":"1","key":"10.1016\/j.sapharm.2016.05.049_bib12","doi-asserted-by":"crossref","first-page":"e84238","DOI":"10.1371\/journal.pone.0084238","article-title":"Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies","volume":"9","author":"Khatib","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2016.05.049_bib13","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinternmed.2011.399","article-title":"Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials","volume":"171","author":"Santschi","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2016.05.049_bib14","first-page":"CD010398","article-title":"The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries","volume":"2","author":"Pande","year":"2013","journal-title":"Cochrane Database Syst Rev [Internet]"},{"key":"10.1016\/j.sapharm.2016.05.049_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4066\/AMJ.2014.2133","article-title":"Impact of community pharmacy-based educational intervention on patients with hypertension in Western Nepal","volume":"7","author":"Sharma","year":"2014","journal-title":"Australas Med J [Internet]"},{"key":"10.1016\/j.sapharm.2016.05.049_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1331\/JAPhA.2012.11015","article-title":"Pharmaceutical care program for elderly patients with uncontrolled hypertension","volume":"52","author":"Aguiar","year":"2012","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.sapharm.2016.05.049_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0975-1483.96623","article-title":"A study on impact of clinical pharmacist interventions on medication adherence and quality of life in rural hypertensive patients","volume":"4","author":"Ramanath","year":"2012","journal-title":"J Young Pharm [Internet]"},{"key":"10.1016\/j.sapharm.2016.05.049_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11096-010-9474-x","article-title":"Pharmacist intervention program to enhance hypertension control: a randomised controlled trial","volume":"33","author":"Morgado","year":"2011","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2016.05.049_bib19","first-page":"806","article-title":"Training pharmacy workers in recognition, management, and prevention of STDs: district-randomized controlled trial","volume":"81","author":"Garcia","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.sapharm.2016.05.049_bib20","doi-asserted-by":"crossref","first-page":"e47750","DOI":"10.1371\/journal.pone.0047750","article-title":"Improved STD syndrome management by a network of clinicians and pharmacy workers in Peru: the PREVEN Network","volume":"7","author":"Garc\u00eda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2016.05.049_bib21","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1345\/aph.1K117","article-title":"Pharmaceutical care in community pharmacies: practice and research in Peru","volume":"41","author":"Alvarez-Risco","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sapharm.2016.05.049_bib22","series-title":"Legislative Decree 1165. [Mechanism to create Inclusive Pharmacies (Farmacias Inclusivas) to improve the access to essencial drugs for affiliates to Integral Health Insurance (Seguro Integral de Salud)]","year":"2013"},{"key":"10.1016\/j.sapharm.2016.05.049_bib23","unstructured":"Poblaci\u00f3n Afiliada a seguro de salud, seg\u00fan \u00e1mbito geogr\u00e1fico, 2004-2013. Instituto Nacional de Estad\u00edstica e Inform\u00e1tica \u2013 Encuesta Nacional de Hogares. Available online at: https:\/\/www.inei.gob.pe\/estadisticas\/indice-tematico\/sociales\/; Accessed on April."},{"key":"10.1016\/j.sapharm.2016.05.049_bib24","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1001\/jama.288.22.2880","article-title":"Helping patients follow prescribed treatment","volume":"288","author":"Haynes","year":"2002","journal-title":"JAMA [Internet]"},{"key":"10.1016\/j.sapharm.2016.05.049_bib25","doi-asserted-by":"crossref","first-page":"e1082","DOI":"10.1097\/MD.0000000000001082","article-title":"Association between loyalty to community pharmacy and medication persistence and compliance, and the use of guidelines-recommended drugs in type 2 diabetes: a cohort study","volume":"94","author":"Dossa","year":"2015","journal-title":"Medicine (Baltimore). [Internet]"},{"issue":"2","key":"10.1016\/j.sapharm.2016.05.049_bib26","first-page":"82","article-title":"Factores de riesgo de las enfermedades cardiovasculares en el Peru (Estudio TORNASOL)","volume":"XXXII","author":"Vega","year":"2006","journal-title":"Rev Peru Cardiol"},{"key":"10.1016\/j.sapharm.2016.05.049_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1524-6175.2003.01460.x","article-title":"How pharmacists can assist physicians with controlling blood pressure","volume":"5","author":"Carter","year":"2003","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.sapharm.2016.05.049_bib28","series-title":"Pharmacy-based Hypertension Management Model: Protocol and Guidelines","year":"2005"},{"key":"10.1016\/j.sapharm.2016.05.049_bib29","series-title":"World Development Indicators","year":"2012"},{"key":"10.1016\/j.sapharm.2016.05.049_bib30","doi-asserted-by":"crossref","first-page":"e112875","DOI":"10.1371\/journal.pone.0112875","article-title":"Adherence to pharmacotherapy and medication-related beliefs in patients with hypertension in Lima, Peru","volume":"9","author":"Fernandez-Arias","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2016.05.049_bib31","series-title":"Identifying the Barriers for Access to Care and Treatment for Arterial Hypertension and Diabetes in\u00a0Lima, Peru \u2013 Executive Summary","author":"Cardenas","year":"2014"},{"key":"10.1016\/j.sapharm.2016.05.049_bib32","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1331\/108658002762063691","article-title":"Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal","volume":"42","author":"Gar\u00e7\u00e3o","year":"2002","journal-title":"J Am Pharm Assoc (Washington, D.C. 1996)"},{"key":"10.1016\/j.sapharm.2016.05.049_bib33","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/hex.12101","article-title":"Pharmacist intervention in improving hypertension-related knowledge, treatment medication adherence and health-related quality of life: a non-clinical randomized controlled trial","volume":"18","author":"Saleem","year":"2015","journal-title":"Health Expect [Internet]"},{"key":"10.1016\/j.sapharm.2016.05.049_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/ijpp.12263","article-title":"Evaluation of a pharmacist-led hypertension preventative and detection service in the Ghanaian community pharmacy: an exploratory study","author":"Marfo","year":"2016","journal-title":"Int J Pharm Pract [Internet]"},{"key":"10.1016\/j.sapharm.2016.05.049_bib35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.puhe.2004.11.009","article-title":"Positive benefits of a pharmacist-managed hypertension clinic in Nigeria","volume":"119","author":"Erhun","year":"2005","journal-title":"Public Health [Internet]"},{"issue":"19","key":"10.1016\/j.sapharm.2016.05.049_bib36","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1161\/CIRCULATIONAHA.107.729863","article-title":"Community-based participatory research from the margin to the mainstream: are researchers prepared?","volume":"119","author":"Horowitz","year":"2009","journal-title":"Circulation [Internet]"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741116301000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741116301000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:12:18Z","timestamp":1761556338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741116301000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1551741116301000"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2016.05.049","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient acceptability of and readiness-to-pay for pharmacy-based health membership plans to improve hypertension outcomes in Lima, Peru","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2016.05.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}